Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Single Site, Open Label Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassemia

NCT05752123 is registered in ClinicalTrials.gov with EdiGene (GuangZhou) Inc. as lead sponsor.

NCT NCT05752123
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05752123 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Single Site, Open Label Study to Evaluate the Safety and Efficacy of ET-01 Transplantation in Subjects with Transfusion Dependent Β-Thalassemia
Lead sponsor
EdiGene (GuangZhou) Inc.
Phase
Not applicable
Overall status
Terminated
Start date
February 18, 2023
Completion date
March 12, 2025
Enrollment
2 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

transfusion dependent beta-thalassaemia